Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

Background: We aimed to assess the extent to which drug persistence is better with non-vitamin K antagonist oral anticoagulants (NOACs) than vitamin K antagonists (VKAs) in atrial fibrillation (AF) patients and to estimate the difference in therapy persistence depending on NOAC dosing regimen (once...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozieł, Monika, Mazurek, Michał, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang-Sheng, Rothman, Kenneth J., Brandes, Axel, Paquette, Miney, Zint, Kristina, França, Lionel Riou, Lu, Shihai, Bartels, Dorothee B., Huisman, Menno V., Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356563/
https://www.ncbi.nlm.nih.gov/pubmed/32586056
http://dx.doi.org/10.3390/jcm9061969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356563/
https://www.ncbi.nlm.nih.gov/pubmed/32586056
http://dx.doi.org/10.3390/jcm9061969

Ejemplares similares